EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Jurij Hanzel, Yuhong Yuan, Shane W Goodwin, Olga Maria Nardone, Joana Roseira, Virginia Solitano, Sudheer Kumar Vuyyuru, Rupert W Leong, Bruce E Sands, Dan Turner, Bjørn Moum, Millie D Long und 14 weitere

Clinical Gastroenterology and Hepatology · 2026-10 · 24 (10) · 2650-2670

DOI: 10.1016/j.cgh.2026.05.015 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-10. Verfasst von Jurij Hanzel und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, University of Ljubljana, UMC Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Inflammatory Bowel Diseases, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Patient-reported outcomes and outcome measures have increasing prominence in clinical trials for inflammatory bowel disease. This systematic review provides an overview of patient-reported outcome measures used in randomized controlled trials, their placebo outcome rates, effect sizes, and operating properties. METHODS: We first searched MEDLINE, Embase and Cochrane CENTRAL up to March 31, 2025, for randomized controlled trials in inflammatory bowel disease using patient-reported outcome measures. In a subsequent search, we searched the databases for studies, regardless of design, reporting on the operating properties of patient-reported outcome measures. In the first part, we summarized the patient-reported outcome measures and outcome definitions. We calculated pooled placebo outcome rates and pooled risk ratios using the DerSimonian-Laird random-effects model. In the second part, we summarized the validity of patient-reported outcome measures. RESULTS: A total of 132 (71 in Crohn's disease, 61 in ulcerative colitis) randomized controlled trials reported 29 patient-reported outcome measures, most commonly the IBD Questionnaire, PRO-2, the Euro QoL survey, and the 36-item Short Form survey. Outcome definitions and reporting formats were highly heterogeneous. Pooled placebo outcome rates for different patient-reported outcome measures were 25.2% to 43.6%. Although superiority over placebo was demonstrated using different patient-reported outcome measure-based outcomes, effect sizes were smaller compared with the primary endpoint for the same trials. A total of 171 studies evaluated the operating properties of 78 patient-reported outcome measures. A minority of instruments underwent extensive validation. These included IBD Control, IBD Disability Index, and IBD Questionnaire. CONCLUSIONS: There is substantial heterogeneity in patient-reported outcome measure reporting in randomized controlled trials. Placebo rates were high and effect sizes low for patient-reported outcome measures. Only a minority of patient-reported outcome measures were extensively validated; of the latter, none were developed following regulatory recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresInflammatory Bowel DiseasesRandomized Controlled Trials as TopicHumansTreatment Outcome

Stichwörter der Autor:innen

Crohn’s DiseasePlaceboUlcerative ColitisValidity

Autor:innen und Institutionen

  • Department of Gastroenterology, University of Ljubljana, UMC Ljubljana, Ljubljana, Slovenia.
  • Department of Medicine, London Health Science Centre, London, Ontario, Canada; Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.
  • Department of Medicine, London Health Science Centre, London, Ontario, Canada.
  • Department of Gastroenterology, University Federico II of Naples, Naples, Italy; Department of Public Health, University Federico II of Naples, Naples, Italy.
  • Gastroenterology Department, Unidade Local de Saúde do Algarve, Portimão, Portugal.
  • Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy; Department of Epidemiology and Biostatistics, Western University, London, Onta…

Zitieren

APA

Hanzel, J., Yuan, Y., Goodwin, S. W., Nardone, O. M., Roseira, J., Solitano, V., Vuyyuru, S. K., Leong, R. W., Sands, B. E., Turner, D., Moum, B., Long, M. D., Louis, E., Reinisch, W., Rubin, D. T., Danese, S., Dignass, A., Siegel, C. A., Panaccione, R., …, & ENDPOINT and PRO Clusters of the International Organization for the Study of Inflammatory Bowel Disease (2026). Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 24(10), 2650-2670. https://doi.org/10.1016/j.cgh.2026.05.015

Vancouver

Hanzel J, Yuan Y, Goodwin SW, Nardone OM, Roseira J, Solitano V, et al. Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 2026;24(10):2650-2670. doi:10.1016/j.cgh.2026.05.015

BibTeX
@article{Hanzel2026,
  author = {Hanzel, Jurij and Yuan, Yuhong and Goodwin, Shane W and Nardone, Olga Maria and Roseira, Joana and Solitano, Virginia and Vuyyuru, Sudheer Kumar and Leong, Rupert W and Sands, Bruce E and Turner, Dan and Moum, Bjørn and Long, Millie D and Louis, Edouard and Reinisch, Walter and Rubin, David T and Danese, Silvio and Dignass, Axel and Siegel, Corey A and Panaccione, Remo and Dubinsky, Marla C and Peyrin-Biroulet, Laurent and Halfvarson, Jonas and Magro, Fernando and Hart, Ailsa and Jairath, Vipul and ENDPOINT and PRO Clusters of the International Organization for the Study of Inflammatory Bowel Disease, ENDPOINT and PRO Clusters of the International Organization for the Study of Inflammatory Bowel Disease},
  title = {Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {10},
  pages = {2650--2670},
  doi = {10.1016/j.cgh.2026.05.015}
}
Kostenlos starten →